Artivion, Inc. Files 8-K on Equity Sales
Ticker: AORT · Form: 8-K · Filed: May 29, 2025 · CIK: 784199
| Field | Detail |
|---|---|
| Company | Artivion, Inc. (AORT) |
| Form Type | 8-K |
| Filed Date | May 29, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: equity-sale, filing
TL;DR
ARTIVION sold unregistered equity, check for dilution.
AI Summary
On May 28, 2025, Artivion, Inc. filed an 8-K report detailing unregistered sales of equity securities. The filing also included other events and financial statements/exhibits. The company is incorporated in Delaware and headquartered in Kennesaw, Georgia.
Why It Matters
This filing indicates potential dilution or changes in share ownership due to unregistered equity sales, which could impact existing shareholders.
Risk Assessment
Risk Level: medium — Unregistered sales of equity can sometimes signal financial distress or lead to dilution for existing shareholders.
Key Players & Entities
- ARTIVION, INC. (company) — Registrant
- May 28, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- Kennesaw, Georgia (location) — Address of principal executive office
FAQ
What specific type of equity securities were sold unregistered?
The filing indicates 'Unregistered Sales of Equity Securities' as an item of information but does not specify the type of securities in the provided text.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on May 28, 2025.
What is Artivion, Inc.'s principal executive office address?
Artivion, Inc.'s principal executive office is located at 1655 Roberts Boulevard, N.W., Kennesaw, Georgia 30144.
What is Artivion, Inc.'s fiscal year end?
Artivion, Inc.'s fiscal year ends on December 31.
What is the SIC code for Artivion, Inc.?
The Standard Industrial Classification (SIC) code for Artivion, Inc. is 3841, which corresponds to SURGICAL & MEDICAL INSTRUMENTS & APPARATUS.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 29, 2025 regarding ARTIVION, INC. (AORT).